Medici per Tumore della vescica all'estero — Pagina 3

Dr. Yusuf Acikgoz is a medical oncologist at Lokman Hekim University Ankara Hospital. He specializes in treating complex cancers, including lung, breast, and liver malignancies. He completed a fellowship at Ohio State University in the United States. Dr. Acikgoz manages treatments like chemotherapy, radioembolization, and immunotherapy.

• Member of the American Society of Clinical Oncology (ASCO).
• Assistant Investigator for Phase III clinical trials, including the CheckMate-649 study.
• Certified in Good Clinical Practice and Human Subjects Protection at Ohio State University.
• Performs diagnostic procedures like biopsy, gastroscopy, and tumor marker testing.

Dr. Elkhan Mammadov is a medical oncologist. He focuses on cancer diagnosis and treatment, including cytotoxic chemotherapy, hormone therapy, targeted therapy (smart drugs), and immunotherapy.

Education: Azerbaijan Medical University, MD (2004–2010). Istanbul University, Istanbul Faculty of Medicine, Internal Medicine training (2014–2019). Istanbul Medipol Mega University Hospital, Medical Oncology subspecialty training (2019–2022).

Experience: 5 years in Internal Medicine. 3 years in Medical Oncology.

Memberships: Turkish Society for Medical Oncology. ESMO (European Society for Medical Oncology). ASCO (American Society of Clinical Oncology).

Il medico è un distinto oncologo medico e internista austriaco con oltre due decenni di esperienza, specializzato in cancro al seno, neoplasie ginecologiche e terapie mirate contro il cancro. Laureato all'Università di Vienna, il medico ha completato la residenza in medicina interna e oncologia medica presso l'Università Medica di Vienna. Il medico ha contribuito ai primi studi clinici sulle terapie mirate ed è un'autorità leader nel trattamento personalizzato del cancro.<\/p>

Attualmente serve come consulente senior presso il Wiener Privatklinik e continua il lavoro accademico presso l'Università Medica di Vienna, il medico si concentra sulla terapia sistemica individualizzata del cancro, l'immunoterapia e la ricerca oncologica traslazionale. La ricerca del medico include lo sviluppo di biomarcatori e meccanismi di resistenza ai farmaci mirati, con pubblicazioni su riviste internazionali di spicco.<\/p>

Il medico è un chirurgo certificato con vasta esperienza in chirurgia mini-invasiva e robotica. Specializzandosi in queste tecniche chirurgiche avanzate, il medico pratica presso il Sourasky Medical Center, dove applica la sua esperienza per migliorare i risultati dei pazienti.<\/p>

Esperta nel trattamento del cancro alla vescica con un focus sulla diagnostica molecolare e sull'immunoterapia. La Dott.ssa Viola Fox, PhD, dirige la Clinica di Ematologia, Oncologia e Cure Palliative presso BKZ Solingen.

• Specializzata in chemioterapia, immunoterapia e terapie mirate
• Membro attivo dell'American Association for Cancer Research
• Specialista qualificata in genetica dal 2016
• Vice Primario presso la Clinica di Pneumologia di Colonia dal 2011

Il medico è un oncologo specializzato nel trattamento dei tumori al seno, ai polmoni e gastrointestinali. Attualmente, il medico pratica presso l'Ospedale Universitario Istinye Liv.

Con una carriera che si estende su molteplici istituzioni prestigiose, il medico ha servito come Specialista in Medicina Interna presso l'Ospedale Statale di Malatya, medico presso la Clinica Oncologica di Ankara e membro del Dipartimento di Oncologia presso l'Ospedale Regionale di Formazione e Ricerca di Erzurum.

Il medico si è laureato presso la Facoltà di Medicina dell'Università di Selcuk e ha ottenuto il titolo di Professore Associato nel 2016.

Il Professor Sebastian Keil dirige la Clinica di Radiologia Diagnostica e Interventistica a Solingen, specializzata in tecniche di imaging avanzate.

• Laureato con lode presso l'Università Julius-Maximilians di Würzburg
• Esperto in risonanza magnetica, tomografia computerizzata e ecografia per interventi complessi
• Ex primario sotto il rinomato Professor Christian K. Kuhl
• Fornisce un'intera gamma di servizi di radiologia interventistica

Il medico è un immunologo con oltre 30 anni di esperienza, specializzato in viroterapia, un campo all'avanguardia nell'immunologia. <\/p>

Si è laureato presso l'Istituto Medico di Riga e ha completato un tirocinio in Medicina Interna. <\/p>

Attualmente è il capo del Centro di Immunologia Clinica presso l'Ospedale Universitario Clinico Pauls Stradins.<\/p>

Dr. Cemil Bilir is a professor of medical oncology at VM Medical Park Pendik Hospital in Istanbul. He specializes in immunotherapy and chemotherapy for lung, breast, and prostate cancers. A former research fellow at Northeastern University in Boston, he focused on pharmaceutical biotechnology and nanomedicine. Dr. Bilir works at a JCI-accredited facility where academic physicians provide around-the-clock care.

• Member of the American Society of Clinical Oncology (ASCO) and ESMO.
• Completed a specialized clinical rotation at the Cleveland Clinic in the U.S.
• Treats complex oncological cases, including stage 4 lung cancer and sarcoma.
• Current Ph.D. student in inorganic chemistry at Sakarya University.

Dr. Ercan Ozden is a medical oncologist and internal medicine specialist at VM Medical Park Pendik. He provides treatment for a wide range of cancers, including breast, lung, and colon cancer. Dr. Ozden trained at Istanbul University, Cerrahpasa Faculty of Medicine. He later completed a medical oncology subspecialty at Kocaeli University.

• Specializes in immunotherapy, target therapy, and chemotherapy for complex cases.
• Treats patients at a JCI-accredited hospital in Istanbul.
• Performs staging and biopsies for liver, lung, and pancreatic tumors.
• Provides targeted immunotherapy using medications like Keytruda.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Mariam Abu Zeid is a clinical oncologist at Shefaa Al Orman International Oncology Hospitals. She is certified by the European Society for Medical Oncology. Dr. Abu Zeid treats solid tumors and hematologic cancers. She holds a Ph.D. in Clinical Oncology and Nuclear Medicine from Ain Shams University.

• Administers chemotherapy, immunotherapy, and targeted treatments for various cancer types.
• Oversees oncology clinical trials and manages treatment-related toxicities.
• Coordinates patient care within multidisciplinary teams for complex staging and diagnosis.
• Practices at an ESMO-accredited center that treats approximately 6,000 patients annually.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Professor Zheng Qiu Hong is Director of the Cell Therapy Research Center and a National Senior Expert in Biotherapy. He is a Professor and Master’s Supervisor at Fujian Medical University. He has more than 30 years of clinical experience in tumor molecular biology and biotherapy. From 2012 to 2013, he was a visiting scholar in stem cell research at the University of Connecticut School of Life Sciences. He previously held leadership roles at Fujian Cancer Hospital. These roles included Director of the Tumor Molecular Biology Laboratory and Director of the Surgical Oncology Research Laboratory. He also served as Deputy Director of the Fujian Key Laboratory of Tumor Biotherapy and Deputy Director of the Biotherapy and Immunotherapy Center.

Appointments include Standing Committee Member of the Biotherapy Committee of the Chinese Research Hospital Association. He is also a Committee Member of the Tumor Immunology and Biotherapy Committee of the Chinese Society for Immunology. In addition, he is Deputy Chair of the Academic Committee of the Xiamen Cell Therapy Research Center at the First Affiliated Hospital of Xiamen University.

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Urologist, Surgeon

Dr. Zohar Dotan heads the Urology Department at Sheba Medical Center in Israel. He is a primary pioneer of robotic and laparoscopic urologic surgery. He specializes in treating complex cancers of the kidney, prostate, and bladder. Dr. Dotan leads the Israeli Uro-Oncology Society and holds a PhD in Genetics.

• Completed a specialized uro-oncology fellowship at Memorial Sloan Kettering in New York.
• Performs robotic radical nephrectomy and da Vinci robotic prostatectomy.
• Authored over 50 scientific publications on advanced urologic cancer treatments.
• Works at Sheba Medical Center, ranked 7th best hospital globally by Newsweek.

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Dr. Maha Yahia is a medical and hemato-oncologist at Shefaa Al Orman International Oncology Hospitals. She served as a Lieutenant Colonel physician in the Egyptian Armed Forces Medical Corps. Dr. Yahia specializes in treatment planning for breast, thoracic, and gastrointestinal cancers. She focuses on immunotherapy, targeted therapy, and complex chemotherapy protocols.

• Former Head of the Clinical Research Support Team at Maadi AFMC.
• Trained at the National Cancer Institute, Cairo University, in hemato-oncology.
• Treats genitourinary, gynecologic, and rare cancers alongside hematologic conditions.
• Works at an ESMO-accredited center that treats 6,000 patients annually.